Comparing LAR and APR for Low Rectal Cancer Outcomes
Surgeons face critical choices between low anterior resection (LAR) and abdominoperineal resection (APR) for low rectal cancer, as outcomes vary and affect patient quality of life.
Newsletter
Intestine and Lower Gastrointestinal Tract
Every new paper in this field, in your inbox.
New Prognostic Tool for Stage III Rectal Cancer Survival
This study identifies how combining perineural invasion and lymph node ratio can improve survival predictions in stage III rectal cancer.
Optimizing Emergency Care for Colorectal Cancer Patients
Emergency management of colorectal cancer is crucial due to high rates of complications and mortality.
Colorectal cancer liver metastases: new strategies for unresectable cases
Surgeons need to adapt to evolving treatments for unresectable colorectal liver metastases (uCRLM) that significantly impact outcomes.
New robotic force feedback enhances safety in rectal surgery
Robotic rectal cancer surgery with da Vinci's new force feedback technology shows promise for reducing tissue stress during procedures.
Bowel Prep’s Role in Elective Colectomy Outcomes
Combining mechanical bowel preparation with oral antibiotics significantly reduces complications after elective colectomy for colon cancer.
International Consensus on Presacral Tumor Management
This consensus sets new guidelines for diagnosing and managing presacral tumors, enhancing surgical practices and patient outcomes.
Omitting Lateral Node Dissection in Rectal Cancer Safe
Lateral pelvic lymph node dissection in rectal cancer patients with responsive nodes after neoadjuvant therapy shows no survival benefit, impacting surgical strategies.
Multimodal Prehabilitation Cuts Complications in Colorectal Surgery
A national study shows that multimodal prehabilitation significantly reduces complications in colorectal cancer surgery, improving outcomes for patients.
Survival Tied to Timely, Guideline-Concordant Care in Cancer
Optimal treatment timing significantly impacts survival in localized colon, lung, and pancreatic cancers.